4.5 Article

BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene

Journal

FEBS LETTERS
Volume 541, Issue 1-3, Pages 149-154

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-5793(03)00315-6

Keywords

insulin-like growth factor; insulin-like growth factor-I receptor; BRCA1; Sp1; breast cancer

Funding

  1. NCI NIH HHS [R01 CA079892, R01 CA090631, CA79892, CA90631] Funding Source: Medline

Ask authors/readers for more resources

The insulin-like growth factor-I receptor (IGF-IR) plays a critical role in breast tumorigenesis and is overexpressed in most primary tumors. BRCA1 is a transcription factor involved in numerous cellular processes, including DNA damage repair, cell growth, and apoptosis. Consistent with its tumor suppressor role, we demonstrated that BRCA1 repressed the activity of co-transfected IGF-IR promoter reporter constructs in a number of breast cancer-derived cell lines. Results of electrophoretic mobility shift assay showed that BRCA1 did not exhibit any specific binding to the IGF-IR promoter, although it prevented binding of Sp1. Co-immunoprecipitation experiments demonstrated that BRCA1 action was associated with specific interaction with Sp1 protein. Furthermore, using a series of glutathione S-transferase-tagged BRCA1 fragments, we mapped the Sp1-binding domain to a segment located between aa 260 and 802. In summary, our data suggest that the IGF-IR gene is a novel downstream target for BRCA1 action. (C) 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available